Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 97, doi. 10.1007/s13402-010-0005-5
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2011 AND VI 34 AND IP 2
Results: 7
1
2
Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 107, doi. 10.1007/s13402-010-0006-4
- By:
- Publication type:
- Article
3
Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 119, doi. 10.1007/s13402-010-0008-2
- By:
- Publication type:
- Article
4
Pathology of hereditary breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 71, doi. 10.1007/s13402-011-0010-3
- By:
- Publication type:
- Article
5
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 141, doi. 10.1007/s13402-011-0019-7
- By:
- Publication type:
- Article
6
Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 89, doi. 10.1007/s13402-011-0021-0
- By:
- Publication type:
- Article
7
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.
- Published in:
- Cellular Oncology (2211-3428), 2011, v. 34, n. 2, p. 131, doi. 10.1007/s13402-011-0009-9
- By:
- Publication type:
- Article